Plains GP Holdings (PAGP) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Feb, 2026Executive summary
Achieved Q4 2024 adjusted EBITDA of $729 million and full-year $2.78 billion, exceeding guidance by 4%.
Completed bolt-on acquisitions totaling ~$670 million, including Ironwood Midstream and the remaining 50% of Midway Pipeline, expanding the asset base.
Repurchased 12.7 million Series A Preferred Units (~18%) and increased annualized distribution by 20% to $1.52 per unit, yielding ~7.5%.
Reported 2024 net income attributable to unitholders of $36 million for Q4 and $772 million for the year, with net cash from operating activities of $726 million and $2.49 billion, respectively.
Financial highlights
Year-end 2024 leverage at 3.0x, below the target range of 3.25x–3.75x, with net debt at $7.27 billion and $2.6 billion committed liquidity.
2024 Adjusted Free Cash Flow (excluding changes in assets & liabilities) was $1.17 billion after distributions.
Q4 Adjusted EBITDA was $729 million, driven by higher crude volumes and pipeline tariff escalation.
Distribution per unit increased 20% in Q4 and 19% for the year.
Raised $1 billion in senior unsecured notes at 5.95% to fund acquisitions; $1 billion in notes mature in October 2025, expected to be refinanced.
Outlook and guidance
2025 Adjusted EBITDA guidance is $2.8–$2.95 billion, with crude oil segment growth and slightly lower NGL segment contributions.
2025 Adjusted Free Cash Flow expected at ~$1.15 billion, reduced by $580 million for bolt-on acquisitions.
Growth capital investment of ~$400 million and maintenance capital of ~$240 million planned for 2025.
Distribution increase to $1.52 per unit annualized, with further increases tied to bolt-on growth and base business performance.
Anticipate leverage at or below the low end of the 3.25x–3.75x target range.
Latest events from Plains GP Holdings
- Cynthia B. Taylor joins as an independent director, enhancing board expertise and ESG oversight.PAGP
Proxy filing13 May 2026 - Sector-leading yield, efficient growth, and robust cash flow drive multi-year distribution growth.PAGP
Investor presentation11 May 2026 - Board urges support for 2025 executive pay plan, addressing ISS concerns and disclosing payout metrics.PAGP
Proxy filing11 May 2026 - 2026 EBITDA guidance raised to $2.88B as NGL sale proceeds target debt reduction.PAGP
Q1 202611 May 2026 - 2025 saw $2.83B EBITDA, higher distributions, and a strategic NGL exit with strong 2026 outlook.PAGP
Q4 202513 Apr 2026 - Proxy covers director elections, auditor ratification, executive pay, and major 2025 strategic actions.PAGP
Proxy filing10 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.PAGP
Proxy filing10 Apr 2026 - Shelf registration allows flexible sale of up to $938.9M in Class A shares for midstream investment.PAGP
Registration filing30 Mar 2026 - Q2 2024 Adjusted EBITDA beat expectations; full-year guidance raised on strong execution.PAGP
Q2 20249 Feb 2026